Neutrophil Activation Marker CD15+ As a Prognostic Factor of Ocular Surface Damage in Type 2 Diabetics. Ukr. j. ophthalmol. 2024, No. 1, 15-19. https://doi.org/10.31288/oftalmolzh202411519.